Trial
NCT03508739
Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition
Phase IIISUSPENDEDOPERATIONALConfidence: HIGH
Sponsor
University of Pennsylvania
Collaborators
—
Condition
Diabetes Mellitus, Type 2
Intervention
Sacubitril/Valsartan 200mg (blinded)
Why stopped
We do not have active funding at this time.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-09-10